441 related articles for article (PubMed ID: 28929255)
1. Carbonic anhydrase IX inhibition affects viability of cancer cells adapted to extracellular acidosis.
Andreucci E; Peppicelli S; Carta F; Brisotto G; Biscontin E; Ruzzolini J; Bianchini F; Biagioni A; Supuran CT; Calorini L
J Mol Med (Berl); 2017 Dec; 95(12):1341-1353. PubMed ID: 28929255
[TBL] [Abstract][Full Text] [Related]
2. The carbonic anhydrase IX inhibitor SLC-0111 sensitises cancer cells to conventional chemotherapy.
Andreucci E; Ruzzolini J; Peppicelli S; Bianchini F; Laurenzana A; Carta F; Supuran CT; Calorini L
J Enzyme Inhib Med Chem; 2019 Dec; 34(1):117-123. PubMed ID: 30362384
[TBL] [Abstract][Full Text] [Related]
3. Targeting carbonic anhydrase IX depletes breast cancer stem cells within the hypoxic niche.
Lock FE; McDonald PC; Lou Y; Serrano I; Chafe SC; Ostlund C; Aparicio S; Winum JY; Supuran CT; Dedhar S
Oncogene; 2013 Oct; 32(44):5210-9. PubMed ID: 23208505
[TBL] [Abstract][Full Text] [Related]
4. Sulfamate inhibitor S4 influences carbonic anhydrase IX ectodomain shedding in colorectal carcinoma cells.
Hektoen HH; Ree AH; Redalen KR; Flatmark K
J Enzyme Inhib Med Chem; 2016 Oct; 31(5):779-86. PubMed ID: 26244271
[TBL] [Abstract][Full Text] [Related]
5. Cellular and radiobiological effects of carbonic anhydrase IX in human breast cancer cells.
Güttler A; Theuerkorn K; Riemann A; Wichmann H; Kessler J; Thews O; Bache M; Vordermark D
Oncol Rep; 2019 Apr; 41(4):2585-2594. PubMed ID: 30720123
[TBL] [Abstract][Full Text] [Related]
6. Inhibition of Carbonic Anhydrase IX Promotes Apoptosis through Intracellular pH Level Alterations in Cervical Cancer Cells.
Temiz E; Koyuncu I; Durgun M; Caglayan M; Gonel A; Güler EM; Kocyigit A; Supuran CT
Int J Mol Sci; 2021 Jun; 22(11):. PubMed ID: 34198834
[TBL] [Abstract][Full Text] [Related]
7. CAIX furthers tumour progression in the hypoxic tumour microenvironment of esophageal carcinoma and is a possible therapeutic target.
Drenckhan A; Freytag M; Supuran CT; Sauter G; Izbicki JR; Gros SJ
J Enzyme Inhib Med Chem; 2018 Dec; 33(1):1024-1033. PubMed ID: 29865880
[TBL] [Abstract][Full Text] [Related]
8. The Carbonic Anhydrase IX inhibitor SLC-0111 as emerging agent against the mesenchymal stem cell-derived pro-survival effects on melanoma cells.
Peppicelli S; Andreucci E; Ruzzolini J; Bianchini F; Nediani C; Supuran CT; Calorini L
J Enzyme Inhib Med Chem; 2020 Dec; 35(1):1185-1193. PubMed ID: 32396749
[TBL] [Abstract][Full Text] [Related]
9. Evaluation of carbonic anhydrase IX as a therapeutic target for inhibition of breast cancer invasion and metastasis using a series of in vitro breast cancer models.
Ward C; Meehan J; Mullen P; Supuran C; Dixon JM; Thomas JS; Winum JY; Lambin P; Dubois L; Pavathaneni NK; Jarman EJ; Renshaw L; Um IH; Kay C; Harrison DJ; Kunkler IH; Langdon SP
Oncotarget; 2015 Sep; 6(28):24856-70. PubMed ID: 26259239
[TBL] [Abstract][Full Text] [Related]
10. A potentiated cooperation of carbonic anhydrase IX and histone deacetylase inhibitors against cancer.
Ruzzolini J; Laurenzana A; Andreucci E; Peppicelli S; Bianchini F; Carta F; Supuran CT; Romanelli MN; Nediani C; Calorini L
J Enzyme Inhib Med Chem; 2020 Dec; 35(1):391-397. PubMed ID: 31865754
[TBL] [Abstract][Full Text] [Related]
11. Hypoxia-inducible factor 1 promotes chemoresistance of lung cancer by inducing carbonic anhydrase IX expression.
Sowa T; Menju T; Chen-Yoshikawa TF; Takahashi K; Nishikawa S; Nakanishi T; Shikuma K; Motoyama H; Hijiya K; Aoyama A; Sato T; Sonobe M; Harada H; Date H
Cancer Med; 2017 Jan; 6(1):288-297. PubMed ID: 28028936
[TBL] [Abstract][Full Text] [Related]
12. Targeting tumor hypoxia: suppression of breast tumor growth and metastasis by novel carbonic anhydrase IX inhibitors.
Lou Y; McDonald PC; Oloumi A; Chia S; Ostlund C; Ahmadi A; Kyle A; Auf dem Keller U; Leung S; Huntsman D; Clarke B; Sutherland BW; Waterhouse D; Bally M; Roskelley C; Overall CM; Minchinton A; Pacchiano F; Carta F; Scozzafava A; Touisni N; Winum JY; Supuran CT; Dedhar S
Cancer Res; 2011 May; 71(9):3364-76. PubMed ID: 21415165
[TBL] [Abstract][Full Text] [Related]
13. Design, synthesis & biological evaluation of ferulic acid-based small molecule inhibitors against tumor-associated carbonic anhydrase IX.
Aneja B; Queen A; Khan P; Shamsi F; Hussain A; Hasan P; Rizvi MMA; Daniliuc CG; Alajmi MF; Mohsin M; Hassan MI; Abid M
Bioorg Med Chem; 2020 May; 28(9):115424. PubMed ID: 32209296
[TBL] [Abstract][Full Text] [Related]
14. Discovery of 4-Hydroxy-3-(3-(phenylureido)benzenesulfonamides as SLC-0111 Analogues for the Treatment of Hypoxic Tumors Overexpressing Carbonic Anhydrase IX.
Bozdag M; Carta F; Ceruso M; Ferraroni M; McDonald PC; Dedhar S; Supuran CT
J Med Chem; 2018 Jul; 61(14):6328-6338. PubMed ID: 29962205
[TBL] [Abstract][Full Text] [Related]
15. Hypoxia-inducible carbonic anhydrase IX and XII promote tumor cell growth by counteracting acidosis through the regulation of the intracellular pH.
Chiche J; Ilc K; Laferrière J; Trottier E; Dayan F; Mazure NM; Brahimi-Horn MC; Pouysségur J
Cancer Res; 2009 Jan; 69(1):358-68. PubMed ID: 19118021
[TBL] [Abstract][Full Text] [Related]
16. Effect of Carbonic Anhydrase IX inhibitors on human endothelial cell survival.
Genah S; Angeli A; Supuran CT; Morbidelli L
Pharmacol Res; 2020 Sep; 159():104964. PubMed ID: 32485281
[TBL] [Abstract][Full Text] [Related]
17. Activation of carbonic anhydrase IX by alternatively spliced tissue factor under late-stage tumor conditions.
Ramchandani D; Unruh D; Lewis CS; Bogdanov VY; Weber GF
Lab Invest; 2016 Dec; 96(12):1234-1245. PubMed ID: 27721473
[TBL] [Abstract][Full Text] [Related]
18. Perfusion-Based Bioreactor Culture and Isothermal Microcalorimetry for Preclinical Drug Testing with the Carbonic Anhydrase Inhibitor SLC-0111 in Patient-Derived Neuroblastoma.
Huo Z; Bilang R; Supuran CT; von der Weid N; Bruder E; Holland-Cunz S; Martin I; Muraro MG; Gros SJ
Int J Mol Sci; 2022 Mar; 23(6):. PubMed ID: 35328549
[TBL] [Abstract][Full Text] [Related]
19. Targeting hypoxic tumor cell viability with carbohydrate-based carbonic anhydrase IX and XII inhibitors.
Morris JC; Chiche J; Grellier C; Lopez M; Bornaghi LF; Maresca A; Supuran CT; Pouysségur J; Poulsen SA
J Med Chem; 2011 Oct; 54(19):6905-18. PubMed ID: 21851094
[TBL] [Abstract][Full Text] [Related]
20. Hypoxia-related carbonic anhydrase IX expression is associated with unfavourable response to first-line therapy in classical Hodgkin's lymphoma.
Méhes G; Matolay O; Beke L; Czenke M; Jóna Á; Miltényi Z; Illés Á; Bedekovics J
Histopathology; 2019 Apr; 74(5):699-708. PubMed ID: 30636023
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
